TET2 and neoplasm: Loss-of-function TET2 mutations and TET2 loss result in aberrant 5mC and 5hmC profiles14, 18, and we recently showed that TET2 likely requires its catalytic activity in HSC/haematopoietic progenitor cells (HPCs) to exert a tumour-suppressive function19.